Users of This Drug Might Be Eligible for Piece of $20M Class-Action Settlement
If you used Solodyn or a generic version of the drug in the past several years, you may be eligible for a class-action settlement.
Three pharmaceutical companies agreed to pay $20 million to settle a lawsuit that accused them of violating antitrust laws by agreeing not to compete on price and keeping generic versions of the drug off the market, according to a release. The companies denied the claims.
Solodyn is usually prescribed to treat acne and other skin conditions.
If you paid for Solodyn between July 23, 2009, and Feb. 25, 2018, you may be eligible for the settlement. People who paid flat copays for their prescriptions, whether brand-name or generic, are not eligible for the settlement. Medicaid recipients are also excluded.
When you file a claim, you’ll be asked how much you spent on Solodyn or its generic versions during the applicable time period. Documentation of the amount you spent is not required, but if you have receipts, an explanation of benefits documents or pharmacy records, you may upload or include them in your claim.
Complete your claim form online or by mail by July 31. The amount awarded to each person who files a claim will depend on the total number of people who submit.
For more details, including frequently asked questions, visit the settlement website.
Lisa Rowan is a senior writer at The Penny Hoarder.
The Penny Hoarder Promise: We provide accurate, reliable information. Here’s why you can trust us and how we make money.